Skip to content

Effects of PA-1 Transcriptional Regulation on Monocyte Function

Angiotensin, the Vascular Endothelium, and Fibrinolysis - The Effects of PAI-1 Transcriptional Regulation on Human Monocyte Function

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00512369
Enrollment
125
Registered
2007-08-07
Start date
2006-03-31
Completion date
2011-07-31
Last updated
2011-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis

Keywords

Metabolic pathways, Atherosclerosis, Monocyte Function

Brief summary

Researching genetic differences in people with no prior medical conditions for better understanding of cardiac diseases through genetic research.

Detailed description

The discovery and subsequent application of small interfering RNA (siRNA) methods to achieve individual gene silencing in mammalian cells is a robust method that is well-described and validated in mammalian cell culture systems. We will apply this technique to achieve post-transcriptional silencing of PAI-1 in monocytes obtained from otherwise healthy volunteers, and study the subsequent loss of this gene's function on the migratory capacity of these cells in the proposed in vitro experimental system. This concept has not yet been demonstrated in the literature, and if validated, would be a novel and fundamental description of the role of PAI-1 in human monocyte biology as related to the development of atherosclerosis.

Interventions

None listed

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Vanderbilt University
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages 18 -50 * No current or past medical problems

Exclusion criteria

* Patients taking prescription drugs (hormonal birth control or herbal supplements may be taken.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026